Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.06 +0.43 (+5.64%)
At close: Nov 11, 2026 · 4:00 PM EST

Eupraxia Pharmaceuticals (EPRX) Gains (Losses) on Sale of Assets & Investments (2023 - 2026)

Updated

Eupraxia Pharmaceuticals (EPRX) recorded Gains (Losses) on Sale of Assets & Investments of -$2,704 in Q2 2026.

Analysis

Eupraxia Pharmaceuticals (EPRX) Gains (Losses) on Sale of Assets & Investments (2023 - 2026) Analysis & Trends

On a TTM basis, Eupraxia Pharmaceuticals' Gains (Losses) on Sale of Assets & Investments came in at -$4,191 as of Jun 30, 2026; for FY2025, it came in at -$2,562.

  • Across earlier years, Gains (Losses) on Sale of Assets & Investments came in at $18,611 in FY2024, -$4,846 in FY2023 and -$6,637 in FY2022.
  • The Q2 2026 figure is the lowest quarterly Gains (Losses) on Sale of Assets & Investments since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Eupraxia Pharmaceuticals 304.87 Mn -174.66 Mn - -1,407.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -1,407.00
Jun 30, 2026 -2,704.00
Dec 31, 2025 -1,487.00
Mar 31, 2025 -1,075.00
Dec 31, 2024 7,243.00
Jun 30, 2024 11,368.00
Dec 31, 2023 -188.00
Jun 30, 2023 -4,520.00
Mar 31, 2023 -138.00
API Access

Eupraxia Pharmaceuticals Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=EPRX&period=max&api_key=YOUR_API_KEY